Mr. Stephen Hanlon has joined EndoShape as Chief Technical Officer. Robert Kline, CEO, said “I am very pleased to welcome Steve to the EndoShape team. He brings over 30 years of innovative medical device industry experience to the development of our embolization products.” Mr. Hanlon has been a leader in engineering and development in the medical device field including catheter navigation technology, radiosurgery systems, oncology patient management systems and other vascular devices. Mr. Hanlon said “I am excited to join EndoShape and the opportunity to be involved in the development of the Company’s polymer based embolization technology.” For more information, please visit our Management Team page.
James McGuckin,MD, Chairman of EndoShape, is pleased to announce the appointment of Mr. Robert Kline as Chief Executive Officer of the Company. Mr. Kline is a serial entrepreneur with over 25 years of healthcare and life science industry experience. In accepting the position, Mr. Kline said "I am excited about the shape memory polymer technology developed at EndoShape and the opportunity to progress development of the Company's portfolio of embolization products." Please visit our Management Team page for more information.
The Medusa® Multi-coil was featured in a live case at the 2016 ISET symposium for Endovascular Therapy in Hollywood, FL. The Medusa® was used successfully to occlude an internal iliac artery as a part of common
iliac artery aneurysm endovascular repair.
Boulder, CO -- The Medusa® Multi-Coil from EndoShape, Inc. will be featured at the 29th Annual American College of Phlebotomy on Friday November 13, 2015 in Orlando, FL.
Dominic J. Tolitano, MD, Chief of Thoracic and Vascular Surgery, Advocate Trinity Hospital will be presenting
his initial 74 patient endovenous embolization experience using the Medusa® Multi-coil to correct lower extremity hemodynamics.
Boulder, Colorado, -- EndoShape, Inc. , an innovative polymer vascular embolization company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 10 th to May 14 th in La Jolla, California. The purpose of the Forum is to help family offices and foundations develop
and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading research institutions, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. A unique gathering of leading family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year. The next Forum is being co-hosted by the community of La Jolla, California including The University of California San Diego, The J. Craig Venter Institute, The Scripps Research Institute, The Sanford-Burnham Medical Research Institute, The Sanford Consortium for Regenerative Medicine, and The Institute of
Boulder, CO -- EndoShape said Monday that is has received 510(k) marketing clearance for its Medusa™ Vascular Plug. The Food and Drug Administration cleared the catheter-delivered device for arterial and
venous embolization in the peripheral vasculature. The device is based on EndoShape's proprietary polymer material technology.
Roughly 50,000 Americans have peripheral vascular embolization procedures annually for a wide variety of indications.
The Medusa™ Vascular Plug is deployed through a catheter placed in the patient's bloodstream and occludes vessels in a single delivery sequence. Due to its non-metallic nature, the Medusa™ Vascular Plug produces minimal CT (Computed Tomography) artifact.
Boulder-based EndoShape said it would launch the device in the U.S. in early 2014.
For more information, please contact us.